Endotoxin-induced activation of equine platelets: Evidence for direct activation of p38 MAPK pathways and vasoactive mediator production

Inflammation Research

Volumn 56, Issue 4, 2007, Pages 154-161

  Brooks, A C ^a   Menzies Gow, N J ^a   Wheeler Jones, C ^a   Bailey, S R ^a   Cunningham, F M ^a   Elliott, J ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Cell signaling; Endotoxin; Platelets

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENDOTOXIN; MITOGEN ACTIVATED PROTEIN KINASE P38; THROMBOXANE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; THROMBOXANE A2;

ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HORSE; IMMUNOBLOTTING; LEUKOCYTE; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RADIOIMMUNOASSAY; SENSITIVITY ANALYSIS; THROMBOCYTE ACTIVATION; ANIMAL; ANIMAL DISEASE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HORSE DISEASE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; ENDOTOXINS; ENZYME INHIBITORS; FEMALE; HORSE DISEASES; HORSES; IMIDAZOLES; LEUKOCYTES; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLATELET ACTIVATION; PYRIDINES; SIGNAL TRANSDUCTION; THROMBOXANE A2;

EID: 34447638908     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-6151-6     Document Type: Article

References (57)

1. Werners AH, Bull S, Fink-Gremmels J. Endotoxaemia: a review with implications for the horse. Equine Vet J 2005; 37: 371-83.
2. Behre G, Schedel I, Nentwig B, Wormann B, Essink M, Hiddemann W. Endotoxin concentration in neutropaenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrob. Agents and Chemother 1992; 36: 2139-46.
3. King JN, Gerring EL. Detection of endotoxin in cases of equine colic. Vet Rec 1988; 123: 269-71.
4. Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y et al. Endotoxin removal by direct hemoperfusion with an absorbant column using polymixin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis 2002; 39: 937-47.
5. Fisher CJ, Marra MN, Palardy JE, Marchbanks CR, Scott RW, Opal SM. Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebocontrolled trial. Crit Care Med 1994; 22: 553-58.
6. Hunt JM, Edwards GB, Clarke KW. Incidence, diagnosis and treatment of postoperative complications in colic cases. Equine Vet J 1986; 18: 264-70.
7. Hood DM, Grosenbaugh DA, Mostafa MB, Morgan SJ, Thomas BC. The role of vascular mechanisms in the development of acute equine laminitis. J Vet Intern Med 1993; 7: 228-34.
8. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol 2005; 83: 196-98.
9. Hwang SB, Lam MH. Species difference in the specific receptors of platelet activating factor. Biochem Pharmacol 1986; 35: 4511-18.
10. Meyers KM, Katz JB, Clemmons RM, Smith JB, Holmsen H. An evaluation of the arachidonate pathway of platelets from companion and food-producing animals, mink, and man. Thromb Res 1980; 20: 13-24.
11. Pelagalli A, Lombardi P, d'Angelo D, Della Morte R, Avallone L, Staiano N. Species variability in platelet aggregation response to different agonists. J Comp Pathol 2002; 127: 126-32.
12. Jarvis GE, Evans RJ. Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro. Res Vet Sci 1994; 57: 317-24.
13. Wilson M, Blum R, Dandona P, Mousa S. Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: a model of human diseases. Clin Exp Pharmacol Physiol 2001; 28: 376-80.
14. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP et al. Platelet Toll-like sreceptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 2006; 107: 637-41.
15. Malhotra R, Priest R, Foster MR, Bird MI. P-selectin binds to bacterial lipopolysaccharide. Eur J Immunol 1998; 28: 983-88.
16. Stahl AL, Svensson M, Morgelin M, Svanborg C, Tarr PI, Mooney JC et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets via TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 2006; 108: 167-76.
17. Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional Toll-like receptor-4. Blood 2005; 106: 2417-23.
18. Nakamura M, Honda Z, Waga I, Matsumoto T, Noma M, Shimizu T. Endotoxin transduces Ca2+ signalling via platelet-activating factor receptor. FEBS Lett 1992; 314: 125-29.
19. Jarvis GE, Evans RJ. Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro. Blood Coagul. Fibrinolysis 1996; 7: 194-98.
20. Jarvis GE, Evans RJ, Heath MF. The role of ADP in endotoxin-induced equine platelet activation. Eur J Pharmacol 1996; 315: 203-12.
21. Ulevitch RJ, Mathison JC, da Silva Correia J. Innate immune responses during infection. Vaccine 2004; 22 Suppl 1: S25-30.
22. Kim SH, Johnson VJ, Shin T-Y, Sharma RP. Selenium attenuates lipopolysaccharide-induced oxidative stress responses through modulation of p38 MAPK and NFkB signalling pathway. Exp Biol Med 2004; 229: 203-13.
23. Chen J-X, Berry L, Christman BW, Meyrick B. Glutathione mediates LPS-stimulated COX-2 expression via early transient p42/44 MAPK activation. J Cell Physiol 2003; 197: 86-93.
24. Ermert M, Kuttner D, Eisenhardt N, Dierkes C, Seeger W, Ermert L. Cyclooxygenase-2-dependent and thromboxane-dependent vascular and bronchial responses are regulated via p38 mitogen-activated protein kinase in control and endotoxin-primed rat lungs. Lab Invest 2003; 83: 333-47.
25. Minuz P, Gaino S, Zuliani V, Tommasoli RM, Benati D, Ortolani R et al. Functional role of p38 mitogen activated protein kinase in platelet activation induced by a thromboxane A2 analogue and by 8-iso-prostaglandin F2alpha. Thromb Haemost 2002; 87: 888-98.
26. Pierangeli SS, Vega-Ostertag M, Harris EN. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. Thromb Res 2004; 114: 467-76.
27. Vega-Ostertag M, Harris EN, Pierangeli SS. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. Arthritis Rheum 2004; 50: 2911-19.
28. Menzies-Gow NJ, Bailey SR, Katz LM, Marr CM, Elliott J. Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. Equine Vet J 2004; 36: 273-78.
29. Bailey SR, Cunningham FM, Elliott J. Endotoxin and dietary amines may increase plasma 5-hydroxytryptamine in the horse. Equine Vet J 2000; 32: 497-504.
30. Kanthou C, Tozer GM. The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells. Blood 2002; 99: 2060-69.
31. Lees P, Ewins CP, Taylor JB, Sedgwick AD. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin. Br Vet J 1987; 143: 462-76.
32. Borsch-Haubold AG, Pasquet S, Watson SP. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J Biol Chem 1998; 273: 28766-72.
33. Menzies-Gow NJ, Bailey SR, Stevens K, Katz L, Elliott J, Marr CM. Digital blood flow and plasma endothelin concentration in clinically endotoxemic horses. Am J Vet Res 2005; 66(4): 630-36
34. Bottoms GD, Johnson M, Ward D, Fessler J, Lamar C, Turek J. Release of eicosanoids from white blood cells, platelets, smooth muscle cells, and endothelial cells in response to endotoxin and A23187. Circ Shock 1986; 20: 25-34.
35. Rickards KJ. Neutrophil phosphodiesterase inhibition in equine chronic obstructive pulmonary disease. PhD Thesis University of London, 2001.
36. Nystrom ML, Barradas MA, Jeremy JY, Mikhailidis DP. Platelet shape change in whole blood: differential effects of endotoxin. Thromb Haemost 1994; 71: 646-50.
37. Washida S. Endotoxin receptor site. I. Binding of endotoxin to platelets. Acta Medi Okayama 1978; 32: 159-67.
38. Halling JL, Hamill DR, Mei-Guey L, Morrision DC. Identification and characterisation of lipopolysaccharide-binding proteins on human peripheral blood cell populations. Infect Immun 1992; 60: 845-52.
39. Montrucchio G, Bosco O, Del Sorbo L, Fascio Pecetto P, Lupia E, Omede P et al. Mechanisms of the priming effect of low doses of lipopolysaccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb Haemost 2003; 90: 872-81.
40. Malhotra R, Priest R, Foster MR, Bird MI. P-selectin binds to bacterial lipopolysaccharides. Eur J Immunol 1998; 28: 983-88.
41. Bottoms GD, Johnson MA, Lamar CH, Fessler JF, Turek JJ. Endotoxin-induced eicosanoid production by equine vascular endothelial cells and neutrophils. Circ Shock 1985; 15: 155-62.
42. Ouellette AL, Evans RJ, Heath FM. Platelets enhance endotoxin-induced monocyte tissue factor (TF) activity in the horse. Res Vet Sci 2004; 76: 31-35.
43. Nemerson Y, Giesen PL. Some thoughts about localisation and expression of tissue factor. Blood Coagulation Fibrin.1998; 9: S45-7.
44. Evans RJ. Blood platelets and their role in the genesis and sequelae of intestinal ischaemia. Equine Vet J 1992; Suppl. 13: 31-7.
45. Rickards KJ, Page CP, Lees P, Gettinby G, Cunningham FM. In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood. J Vet Pharmacol Ther 2003; 26: 123-30.
46. Cambridge H, Lees P, Hooke RE, Russell CS. Antithrombotic actions of aspirin in the horse. Equine Vet J 1991; 23: 123-7.
47. Izumi T, Honda Z, Mutoh H, Kume K, Shimazu T. Regulation and signal transduction of PAF receptor. Adv Prostaglandin Thromboxane Leukotr Res 1995; 23: 461-6.
48. Ishii S, Nagase T, Shimizu T. Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat 2002; 68-69: 599-609.
49. Weinstein SL, Sanghera JS, Lemke K, DeFranco AL, Pelech SL. Bacterial lipopolysaccharide induced tyrosine phosphorylation and activation of mitogen activated protein kinases in macrophages. J Biol Chem 1992; 267: 14955-62.
50. Nahas N, Molski TF, Fernandez GA, Sha'afi RI. Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. Biochem J 1996; 318: 247-53.
51. Branger J, van den Blink B, Weijer S, Madwed J, Bos CL, Gupta A et al. Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J Immunol 2002; 168: 4070-77.
52. Branger J, van den Blink B, Weijer S, Gupta A, van Deventer SJ, Hack CE et al. Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. Blood 2003; 101: 4446-48.
53. Kuliopulos A, Mohanlal R, Covic L. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation. Thromb Haemost 2004; 92: 1387-93.
54. Nagano S, Otsuka T, Niiro H, Yamaoka K, Arinobu Y, Ogami E et al. Molecular mechanisms of lipopolysaccharide-induced cyclooxygenase-2 expression in human neutrophils: involvement of the mitogen-activated protein kinase pathway and regulation by anti-inflammatory cytokines. Int Immunol 2002; 14(7): 733-40.
55. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005; 122(3): 379-91.
56. Evangelista V, Manarini S, Di Santo A, Capone ML, Ricciotti E, Di Francesco L et al. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res 2006; 98(5): 593-5.
57. Pearson FC, Dubczak J, Weary M, Bruszer G, Donohue G. Detection of endotoxin in the plasma of patients with gram-negative bacterial sepsis by the Limulus amoebocyte lysate assay. J Clin Microbiol 1985; 21(6): 865-8.